HilleVax, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 26.89 million compared to USD 67.89 million a year ago. Basic loss per share from continuing operations was USD 0.71 compared to USD 10.06 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.79 USD | +6.41% | +3.98% | -20.31% |
Apr. 05 | Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing | MT |
Mar. 21 | Stifel Adjusts HilleVax Price Target to $34 From $30, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.31% | 616M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- HLVX Stock
- News HilleVax, Inc.
- HilleVax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023